NPS's Nader on Drug Research, Growth Strategy
Feb. 25 (Bloomberg) -- Francois Nader, chief excutive officer for NPS Pharmaceuticals Inc., talks about cost strategy and product development.
Nader speaks with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance." Stanley Collender, managing director for Qorvis Communications LLC, also speaks. (Source: Bloomberg)